Menu
About Galvanize
Therapeutics
Galvanize is a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, aiming to deliver life-changing solutions to patients and their doctors.
We create Pulsed Electric Field technologies capable of targeting cells involved in disease processes, in ways unparalleled to other devices or drugs.
We study our technologies in well designed clinical trials to ensure safety & efficacy.
We partner with doctors and healthcare systems so that patients can access our therapies.
We study our technologies in well designed clinical trials to ensure safety & efficacy.
We partner with doctors and healthcare systems so that patients can access our therapies.
Galvanize Leadership
Board of Directors
Investors
Galvanize Therapeutics was created and incubated by ATP (Apple Tree Partners).

Founded in 1999, ATP is a leader in life sciences venture capital, with $2.65 billion in committed capital and offices in New York, London, San Francisco, and Cambridge, MA. ATP creates companies starting at various stages, from pre-IP ideas to asset spinouts, investing in them from seed stage through IPO and beyond. The core of ATP’s strategy is to provide flexible capital and access to a world-class team of venture partners and EIRs, to build sustainable, research-driven enterprises that improve human lives. For more information, visit www.appletreepartners.com.
Other investors in Galvanize Therapeutics include Intuitive Surgical, and Gilmartin Capital.
Other investors in Galvanize Therapeutics include:
Intuitive Surgical
Lorem ipsum dolor sit amet, his eu sapientem gloriatur incorrupte. Mei cu accusamus intellegam, his cu quod sale maiorum. Est omittam albucius et, et graece facilis ius. Mea iisque fuisset pertinacia ea, nam et graece eirmod.
Gilmartin Capital
Lorem ipsum dolor sit amet, his eu sapientem gloriatur incorrupte. Mei cu accusamus intellegam, his cu quod sale maiorum. Est omittam albucius et, et graece facilis ius. Mea iisque fuisset pertinacia ea, nam et graece eirmod.